Georgia College & State University jumps to No. 4 “Most Innovative School” in U.S. News & World Report's 2025 Best Colleges
September 24, 2024 00:27 ET
|
Georgia College & State University
Milledgeville, Georgia, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Georgia College & State University, the state’s designated public liberal arts university, gained among the elite top 20 universities...
Brookhaven announces International Festival 2024 stage lineup
September 17, 2024 12:59 ET
|
City of Brookhaven
The Brookhaven International Festival takes place October 19-20, featuring musical headliners Tito Puente Jr. and The Itals.
PharmAla to supply Johns Hopkins Medicine for Clinical Trial
September 11, 2024 08:55 ET
|
PharmAla Biotech
PharmAla completes sales agreement with Johns Hopkins Medicine, terminates contract with Red Light Holland, to present novel molecule at conference.
Lendmark Financial Services Expands Georgia Presence with Douglas Branch, Marking its First Location in Coffee County and 51st in the State
August 30, 2024 11:30 ET
|
Lendmark Financial Services, LLC
DOUGLAS, Ga., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Lendmark Financial Services (Lendmark), a leading provider of household credit and consumer loan solutions, continues to expand its Georgia...
Key Highlights of Lighthouse Fusion
August 27, 2024 09:00 ET
|
Lighthouse Autism Center
Lighthouse Autism Center expands its speech therapy program with more dually certified SLPs and BCBAs, offering better outcomes for children with autism.
Cedars Preschool Expands to Macon
August 19, 2024 07:41 ET
|
O2B Early Education
Cedars Preschool proudly opens its 13th location in Georgia, and expands their reach to Macon-Bibb county.
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
August 09, 2024 18:18 ET
|
PharmAla Biotech
PharmAla expresses disappointment in USFDA's decision to request a third Phase 3 for MDMA and announces the patent granting for a safer MDMA analog variant
Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference
August 07, 2024 08:00 ET
|
Compass Therapeutics
BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
Compass Therapeutics Completes Patient Enrollment in COMPANION-002, a Randomized Study of CTX-009 in Combination with Paclitaxel, and Provides an Update on the Development Plan in Biliary Tract Cancer
August 06, 2024 08:00 ET
|
Compass Therapeutics
Completed enrollment of the planned 150 patients in COMPANION-002, a Phase 2/3 trial of CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced Metastatic...
Truxton Expands in Georgia With Key Appointments
August 02, 2024 12:54 ET
|
Truxton Trust Company
Truxton announced that Jennifer Verbrigghe CFP®, CTFA, has joined the firm as SVP, Wealth Advisor, and Tia Marrano has been promoted to AVP, Wealth Advisor